Section Arrow
QUCY.NASDAQ
- Mainz Biomed N.V.
Quotes are at least 15-min delayed:2026/03/19 08:55 EDT
Pre Market
Last
 0.6
-0.0044 (-0.73%)
Bid
0.6
Ask
0.615
High 0.615 
Low 0.553 
Volume 22.57K 
Regular Hours (Closed)
Last
 --
-- (--)
Day High 
-- 
Prev. Close
0.6044 
1-M High
-- 
Volume 
-- 
Bid
0.6
Ask
0.615
Day Low
-- 
Open
-- 
1-M Low
-- 
Market Cap 
10.56M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA -- 
20-SMA -- 
50-SMA -- 
52-W High -- 
52-W Low -- 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-5.28/-0.03
Enterprise Value
11.43M
Balance Sheet
Book Value Per Share
0.20
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
893.99K
Operating Revenue Per Share
0.06
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
XWELXWELL-------- 
Pre Market 1.345 +0.025 +1.89%
XGNExagen-------- 
Pre Market 2.98 -0.04 -1.32%
WGSGeneDx Holdings Corp-------- 
Pre Market 72.1 +1.41 +1.99%
WATWaters Corp-------- 
Pre Market 296.2 +1.15 +0.39%
VCYTVeracyte-------- 
Pre Market 32.9 -0.38 -1.14%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.